Skip to main content
SpringerLink
Log in

Stereotactic Body Radiotherapy: A Practical Guide for the Delivery of Accelerated Partial Breast Irradiation

  • Chapter
  • First Online:
Book cover Stereotactic Body Radiotherapy

  • 1421 Accesses

Abstract

Post-operative whole-breast irradiation (WBI) has been used in the last several decades to offer early-stage breast cancer patients options to preserve their breasts. The standard traditional external beam radiation treats the whole breast over a 6–7 week course; however, it is inconvenient and does have potential toxicity to heart, lung, bone, and soft tissues. Over the last decade, accelerated partial breast irradiation (APBI) allows the majority of these patients an attractive alternative to traditional radiation by treating part of the breast over 1–2 weeks. There are more than a dozen APBI techniques emerging over the last decade using various modalities of radiation including superficial X-ray, high-energy photon, proton beam, high-dose rate and low dose-rate brachytherapy. Of these, stereotactic body radiation therapy (SBRT) is an attractive option and is the focus of this chapter. SBRT offers patients the delivery ease of external beam radiotherapy (reproducibility factor) without the protracted time commitment seen with WBI (convenience factor). In addition, SBRT offers increased accuracy of irradiation delivery (target precision factor) without the inherent invasiveness (quality-of-life factor) of a brachytherapy implant. These SBRT abilities will likely increase the number of candidates for APBI, particularly those patients with difficult to treat anatomy (large/pendulous breasts), busy working women, elderly or disabled patients and those who live far from a radiation therapy clinic. This chapter describes one technique of SBRT for APBI using the CyberKnife system and preliminary data on a small group of patients demonstrates the feasibility and minimal side effects. More clinical studies need to be conducted to explore this new technique with end points of in-breast tumor recurrence, cost effectiveness, and quality of life endpoints including cosmesis, side effects and perceived convenience.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. National Institutes of Health, NIH Consensus Statement, Treatment of early stage breast cancer. 1990; 8:1–19.

    Google Scholar 

  2. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  3. Jacobson JA, Danforth DN, Cowan KH, d’Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907–11.

    Article  CAS  PubMed  Google Scholar 

  4. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–50.

    Article  PubMed  Google Scholar 

  5. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992:19–25. http://www.ncbi.nlm.nih.gov/pubmed/1627427.

  6. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  7. Sarrazin D, Le MG, Arriagada R, Contesso G, Fontaine F, Spielmann M, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989;14:177–84.

    Article  CAS  PubMed  Google Scholar 

  8. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. Early Breast Cancer Trialists’ Collaborative Group. N Engl J Med. 1995;333:1444–55.

    Google Scholar 

  9. National Cancer Institute. Cancer trends progress report—2005 update. Bethesda: NIH, DHHS; 2005.

    Google Scholar 

  10. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992;84:683–9.

    Article  CAS  PubMed  Google Scholar 

  11. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 2003;95:1205–10.

    Article  PubMed  Google Scholar 

  12. Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004;60:722–30.

    Article  PubMed  Google Scholar 

  13. Fan J, Hayes S, Freedman G, Anderson P, Li J, Wang L, et al. Planning the breast boost: dosimetric comparison of CyberKnife, photo mini tangents, IMRT, and electron techniques. Int J Radiat Oncol Biol Phys. 2010;78:S3306.

    Google Scholar 

  14. Heinzerling JH, Ding C, Ramirez E, Chang K, Anderson JF, Edwards CM, et al. Comparative dose-volume analsysis for CyberKnife and 3D conformal partial breast irradiation treatment of early stage breast cancer. Int J Radiat Oncol Biol Phys. 2010;78:S3390.

    Article  Google Scholar 

  15. Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141–9.

    Article  CAS  PubMed  Google Scholar 

  16. Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–7.

    Article  CAS  PubMed  Google Scholar 

  17. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328:1587–91.

    Article  CAS  PubMed  Google Scholar 

  18. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet. 1996;348:708–13.

    Article  CAS  PubMed  Google Scholar 

  19. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet. 2000;355:1757–70.

    Google Scholar 

  20. Uppsala Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst. 1990;82:277–82.

    Article  Google Scholar 

  21. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.

    Article  CAS  PubMed  Google Scholar 

  22. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF. “Residual” mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35:739–47.

    Article  CAS  PubMed  Google Scholar 

  23. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 1990;8:113–8.

    CAS  PubMed  Google Scholar 

  24. Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst. 1994;86:717–22.

    Article  CAS  PubMed  Google Scholar 

  25. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer. 1986;57:1717–24.

    Article  CAS  PubMed  Google Scholar 

  26. Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990;19:833–42.

    Article  CAS  PubMed  Google Scholar 

  27. Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg. 1990;211:250–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  28. Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647–59.

    Article  CAS  PubMed  Google Scholar 

  29. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 2000;180:299–304.

    Article  CAS  PubMed  Google Scholar 

  30. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80(3):121–8; discussion 9.

    Google Scholar 

  31. Perera F, Engel J, Holliday R, Scott L, Girotti M, Girvan D, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol. 1997;65(4):263–7; discussion 7–8.

    Google Scholar 

  32. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993–2001.

    CAS  PubMed  Google Scholar 

  33. Arthur DW, Winter K, Kuske RR, Bolton J, Rabinovitch R, White J, et al. A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95–17. Int J Radiat Oncol Biol Phys. 2008;72(2):467–73.

    Google Scholar 

  34. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289–93.

    Article  PubMed  Google Scholar 

  35. Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):889–97.

    Google Scholar 

  36. Arthur DW, Koo D, Zwicker RD, Tong S, Bear HD, Kaplan BJ, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys. 2003;56(3):681–9.

    Google Scholar 

  37. Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HM, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32A(4):608–11.

    Google Scholar 

  38. Lawenda BD, Taghian AG, Kachnic LA, Hamdi H, Smith BL, Gadd MA, et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys. 2003;56(3):671–80.

    Google Scholar 

  39. Baglan KL, Sharpe MB, Jaffray D, Frazier RC, Fayad J, Kestin LL, et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2003;55(2):302–11.

    Google Scholar 

  40. Formenti SC, Truong MT, Goldberg JD, Mukhi V, Rosenstein B, Roses D, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004;60(2):493–504.

    Google Scholar 

  41. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer. 2001;37:2178–83.

    Article  CAS  PubMed  Google Scholar 

  42. Vaidya JS, Tobias JS, Baum M, Wenz F, Kraus-Tiefenbacher U, D’Souza D, et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol. 2005;15(2):84–91.

    Google Scholar 

  43. Vicini F, Beitsch P, Quiet C, Gittleman M, Zannis V, Fine R, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;79:808–17.

    Article  PubMed  Google Scholar 

  44. Hepel JT, Tokita M, MacAusland SG, Evans SB, Hiatt JR, Price LL, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75:1290–6.

    Article  PubMed  Google Scholar 

  45. Jagsi R, Ben-David MA, Moran JM, Marsh RB, Griffith KA, Hayman JA, et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys. 2010;76:71–8.

    Article  PubMed  Google Scholar 

  46. Patel RR, Christensen ME, Hodge CW, Adkison JB, Das RK. Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results. Int J Radiat Oncol Biol Phys. 2008;70:970–3.

    Article  PubMed  Google Scholar 

  47. Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer Jr CR. The CyberKnife robotic radiosurgery system in 2010. Technol Cancer Res Treat. 2010;9:433–52.

    Article  CAS  PubMed  Google Scholar 

  48. Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001.

    Article  PubMed  Google Scholar 

  49. Weed DW, Yan D, Martinez AA, Vicini FA, Wilkinson TJ, Wong J. The validity of surgical clips as a radiographic surrogate for the lumpectomy cavity in image-guided accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2004;60:484–92.

    Article  PubMed  Google Scholar 

  50. NSABP B-39, RTOG 0413: A Randomized Phase III Study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol. 2006;4(10):719–21.

    Google Scholar 

  51. Formenti SC. External-beam partial-breast irradiation. Semin Radiat Oncol. 2005;15:92–9.

    Article  PubMed  Google Scholar 

  52. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol. 2008;9:331–41.

    Article  CAS  PubMed  Google Scholar 

  53. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.

    Article  CAS  PubMed  Google Scholar 

  54. Patel RR, Becker SJ, Das RK, Mackie TR. A dosimetric comparison of accelerated partial breast irradiation techniques: multicatheter interstitial brachytherapy, three-dimensional conformal radiotherapy, and supine versus prone helical tomotherapy. Int J Radiat Oncol Biol Phys. 2007;68:935–42.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Swedish Radiosurgery Department, Swedish Medical Center, Swedish Radiosurgery Center, Seattle, WA, USA

    Sandra S. Vermeulen MD

  2. Clinical Research, GI, Lung, and Breast Services, University of California of San Diego, Scripps Proton Therapy Center, San Diego, CA, USA

    Huan B. Giap MD, PhD

  3. Department of Radiation Oncology, Swedish Cancer Institute, Radiosurgery Center, Seattle, WA, USA

    Cristian Cotrutz PhD

  4. Department of Radiation Oncology, Valley Medical Center, Renton, WA, USA

    Robert M. Douglas MD

  5. Department of Radiation Oncology, Tumor Institute Radiation Onc., Seattle, WA, USA

    Astrid Morris MD

Authors
  1. Sandra S. Vermeulen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huan B. Giap MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cristian Cotrutz PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert M. Douglas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Astrid Morris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandra S. Vermeulen MD .

Editor information

Editors and Affiliations

  1. Guy's Hospital, London, United Kingdom

    Andrew Gaya

  2. Dept. Radiation Oncology, Harvard Medical School Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

    Anand Mahadevan

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Vermeulen, S.S., Giap, H.B., Cotrutz, C., Douglas, R.M., Morris, A. (2015). Stereotactic Body Radiotherapy: A Practical Guide for the Delivery of Accelerated Partial Breast Irradiation. In: Gaya, A., Mahadevan, A. (eds) Stereotactic Body Radiotherapy. Springer, London. https://doi.org/10.1007/978-0-85729-597-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-597-2_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-596-5

  • Online ISBN: 978-0-85729-597-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation